IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Peregrine Pharmaceuticals in

CUSIP: 713661502 | 67 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

IFP Advisors, Inc3,043
0.0% of portfolio›$12
StyleTurnoverLocationFiled
IFP Advisors, Inc
3,043$120.0%GrowthLowTampa, FL2019-06-03